. CRD DC-SIGN 1 H-15 N HQSC: specific aminoacid crosspeak chemical shift perturbation upon increasing additions of ligands: left fucose (7), middle blood group B type VI (2) , right blood group A type VI (1). Scheme S1: The synthesis of methyl 4-deoxy-4-fluoro--L-fucopyranoside
Synthetic procedures and characterization data

Methyl 2,3-di-O-benzoyl--L-quinovoside 14
To a solution of ester α-13 1 (5.80 g, 15.0 mmol) in CH 2 Cl 2 (43 mL) and pyridine (11 mL) at 0 °C was added triflic anhydride (4.90 mL, 30.0 mmol) dropwise. After 45 min at 0 °C the reaction was quenched with water (50 mL), the aqueous phase separated and then extracted with CH 2 Cl 2 (2 x 50 mL). The combined organic phases were dried over 
Methyl--L-quinovoside (15)
To a solution of ester 14 (3.55 g, 9.2 mmol, 1 eq) in MeOH (74 mL) was added NaOMe (25% wt solution in MeOH, 0.63 mL, 2.8 mmol). After 45 min Amberlite® IR 120 was added until pH = 7 was reached, the RM was filtered, concentrated in vacuo and then 
